Pramodini Medicare Limited (NSE:PRAMODINI)
India · Delayed Price · Currency is INR 118.00
-0.10 (-0.08%)
At close: Aug 21, 2026
Pramodini Medicare Revenue
In the fiscal year ending March 31, 2026, Pramodini Medicare had annual revenue of 622.88M INR with 62.90% growth. Pramodini Medicare had revenue of 178.35M in the quarter ending March 31, 2026.
Revenue
622.88M
Revenue Growth
+62.90%
P/S Ratio
4.18
Revenue / Employee
3.87M
Employees
161
Market Cap
2.60B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 622.88M | 240.50M | 62.90% |
| Mar 31, 2025 | 382.38M | 30.08M | 8.54% |
| Mar 31, 2024 | 352.30M | 46.48M | 15.20% |
| Mar 31, 2023 | 305.81M | 55.06M | 21.96% |
| Mar 31, 2022 | 250.75M | 65.15M | 35.10% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.76B |
| One Global Service Provider | 5.13B |
| Chandan Healthcare | 2.94B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 841.37M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 259.03M |
| Clinitech Laboratory | 94.91M |